Karyopharm Grants Inducement Awards to Newly-Hired Employees Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm Therapeutics granted stock options and restricted stock units to seven new employees as inducements for joining the company. The stock options have an exercise price of $5.62 per share and vest over four years, while the RSU awards vest over three years. These awards were made pursuant to the company's 2022 Inducement Stock Incentive Plan and are in line with Nasdaq Listing Rule 5635(c)(4).